EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulation of MicroRNA-181a-5p Targets TNFAIP3 to Promote MIF-CXCR4 Signaling and Immune Inflammatory Remodeling in Chronic Myeloid Leukemia

Noha Mohammed Saleh iD, Rawaa AlChalabi, Yasir Issa, Shahad Nassurat

F1000Research · 26.03.2026 · 14 · 1460

DOI: 10.12688/f1000research.172236.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, online erschienen am 26.03.2026. Verfasst von Noha Mohammed Saleh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pathology, Al Iraqia University College of Medicine, baghdad, 3, 10079, Iraq. Hauptthemen laut MEDLINE: Tumor Necrosis Factor alpha-Induced Protein 3, MicroRNAs, Receptors, CXCR4, Macrophage Migration-Inhibitory Factors. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The non-coding RNAs, particularly microRNA-181a-5p target the expression of tumor necrosis factor alpha-induced protein 3 (TNFAIP3) a key negative regulator of NF-κB signaling and affect the levels of macrophage migration inhibitory factor (MIF) and chemokine receptor type 4 (CXCR4) in chronic myeloid leukamia (CML).

Methods

The study included 57 individuals with chronic myeloid leukemia (CML) and 33 healthy individuals. Hematological parameters (Hb, RBCs, WBCs and platelets) were assessed. The serum levels of MIF, TNFAIP3 and CXCR4 were measured using ELISA Technique. Quantitative real-time polymerase chain reaction was performed to assess miR-181a expression. The potential targets and immune associated pathways of miR-181a were predicted using bioinformatics tools including TargetScan, miRTarBase, STRING, DAVID, and Enrichr. Statistical analysis included ROC curve evaluation, Pearson correlation, and t-tests.

Results

Compared to controls, CML patients exhibited reduced platelets, Hb and RBC while elevated WBCs recorded. There were significantly elevated serum levels of MIF and CXCR4, and reduced levels of TNFAIP3 (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor alpha-Induced Protein 3MicroRNAsReceptors, CXCR4Macrophage Migration-Inhibitory FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansMaleFemaleSignal TransductionMiddle AgedAdultInflammationIntramolecular Oxidoreductases

Stichwörter der Autor:innen

CXCR4Chronic myeloid leukemiaImmune biomarkersInflammationMIFNF-κB signalingTNFAIP3.miR-181a

Substanzen

Tumor Necrosis Factor alpha-Induced Protein 3MicroRNAsReceptors, CXCR4Macrophage Migration-Inhibitory FactorsTNFAIP3 protein, humanMIrn181 microRNA, humanMIF protein, humanCXCR4 protein, humanIntramolecular Oxidoreductases

Autor:innen und Institutionen

  • Pathology, Al Iraqia University College of Medicine, baghdad, 3, 10079, Iraq.
  • Department of Molecular and Medical Biotechnology, College of Biotechnology, Al-Nahrain University, baghdad, 3, 10079, Iraq.
  • College of Health and Medical Techniques/ Baghdad, Middle Technical University, baghdad, 3, 10079, Iraq.
  • Biology, Middle East University, baghdad, 3, 10079, Iraq.

ORCID-Profile: Noha Mohammed Saleh

Zitieren

APA

Mohammed Saleh, N., AlChalabi, R., Issa, Y., & Nassurat, S. (2026). Dysregulation of MicroRNA-181a-5p Targets TNFAIP3 to Promote MIF-CXCR4 Signaling and Immune Inflammatory Remodeling in Chronic Myeloid Leukemia. F1000Research, 14, 1460. https://doi.org/10.12688/f1000research.172236.3

Vancouver

Mohammed Saleh N, AlChalabi R, Issa Y, Nassurat S. Dysregulation of MicroRNA-181a-5p Targets TNFAIP3 to Promote MIF-CXCR4 Signaling and Immune Inflammatory Remodeling in Chronic Myeloid Leukemia. F1000Research. 2026;14:1460. doi:10.12688/f1000research.172236.3

BibTeX
@article{MohammedSaleh2026,
  author = {Mohammed Saleh, Noha and AlChalabi, Rawaa and Issa, Yasir and Nassurat, Shahad},
  title = {Dysregulation of MicroRNA-181a-5p Targets TNFAIP3 to Promote MIF-CXCR4 Signaling and Immune Inflammatory Remodeling in Chronic Myeloid Leukemia},
  journal = {F1000Research},
  year = {2026},
  volume = {14},
  pages = {1460},
  doi = {10.12688/f1000research.172236.3}
}
Kostenlos starten →